Tempus AI is accelerating foundation model development by utilizing digital slide archives from Memorial Sloan Kettering Cancer Center and Microsoft Azure.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tempus AI is accelerating foundation model development by utilizing digital slide archives from Memorial Sloan Kettering Cancer Center and Microsoft Azure.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Memorial Sloan Kettering Cancer Center
cancer treatment and research institution in New York City, United States
-
Microsoft
American multinational technology corporation
- Nvidia is expanding its platform deployment across major cloud providers, including Google Cloud and Microsoft Azure.
- Cloud giants, including Microsoft, Amazon, Anthropic, OpenAI, and Google, are benefiting from overall AI market growth while navigating corporate cost containment and future market competition.
-
Tempus
biotechnology company based in Chicago, Illinois
Related events
- Microsoft's Azure revenue hit $100B driven by AI, while Apple focuses on selling high-margin devices for local AI processing.
- Gartner and Microsoft discussed enterprise AI trends in a partnership.
- Snowflake, Microsoft, and Siemens announced partnerships to drive AI-driven revenue growth and expand AI Data Cloud services.
- Microsoft, Anthropic, and CrowdStrike are involved in a consortium called Project Glasswing, focusing on AI security and leveraging cloud platforms like Azure.
- Both Microsoft and Boston Consulting Group are major players in the AI agent market.
Coverage
Newest first; wire copies grouped- MedTech DiveTempus inks $81M Paige buyout to support AI model development This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newslet